Breaking News, Financial News

AstraZeneca 4Q08

Nexium sales were $1.3 billion in the quarter (+6%) but down 2% for the year to $5.2 billion. Losec/Prilosec sales were down 11% to $264 million in the quarter and down 14% to $1.1 billion for the year due to generic competition.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

AstraZeneca 4Q Revenues: $8.2 billion (flat) 4Q Earnings: $1.3 billion (flat) FY Revenues: $31.6 billion (+7%) FY Earnings: $6.1 billion (+9%) Comments: Nexium sales were $1.3 billion in the quarter (+6%) but down 2% for the year to $5.2 billion. Losec/Prilosec sales were down 11% to $264 million in the quarter and down 14% to $1.1 billion for the year due to generic competition. Crestor sales were $987 million in the quarter (+30%) and $3.6 billion for the year (+26%). Seloken /T...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters